WFA
INO icon

Wipfli Financial Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Wipfli Financial Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Buy
+92
New +$2.35K ﹤0.01% 2292

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wipfli Financial Advisors's INO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Inovio Pharmaceuticals (INO) in Q3 2022: 92 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2292 among its holdings.

182 funds tracked by Wall St. Rank hold INO as of Q3 2022.

  • Wipfli Financial Advisors held 92 shares of Inovio Pharmaceuticals worth $2K as of Q3 2022.
  • Inovio Pharmaceuticals was a new Wipfli Financial Advisors position in Q3 2022.
  • Inovio Pharmaceuticals made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2292 holding.
  • 182 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.